The surprising discovery that RNAs are the predominant
gene products
to emerge from the human genome catalyzed a renaissance in RNA biology.
It is now well-understood that RNAs act as more than just a messenger
and comprise a large and diverse family of ribonucleic acids of differing
sizes, structures, and functions. RNAs play expansive roles in the
cell, contributing to the regulation and fine-tuning of nearly all
aspects of gene expression and genome architecture. In line with the
significance of these functions, we have witnessed an explosion in
discoveries connecting RNAs with a variety of human diseases. Consequently,
the targeting of RNAs, and more broadly RNA biology, has emerged as
an untapped area of drug discovery, making the search for RNA-targeted
therapeutics of great interest. In this Microperspective, I highlight
contemporary learnings in the field and present my views on how to
catapult us toward the systematic discovery of RNA-targeted medicines.